Oklo (NYSE:OKLO) Posts Quarterly Earnings Results, Misses Estimates By $0.10 EPS

Oklo (NYSE:OKLO) announced its earnings results on Tuesday. The company reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.10), FiscalAI reports. During the same period in the prior year, the company posted ($0.74) earnings per share.

Oklo Stock Down 0.9%

Shares of NYSE:OKLO traded down $0.54 during trading on Wednesday, reaching $59.99. 1,905,169 shares of the company traded hands, compared to its average volume of 10,522,364. The firm has a market capitalization of $9.37 billion, a PE ratio of -110.65 and a beta of 0.80. Oklo has a 52 week low of $17.42 and a 52 week high of $193.84. The company’s 50 day moving average is $75.08 and its two-hundred day moving average is $95.27.

Insider Transactions at Oklo

In other Oklo news, CFO Richard Craig Bealmear sold 72,090 shares of the stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $60.00, for a total transaction of $4,325,400.00. Following the sale, the chief financial officer directly owned 386,008 shares in the company, valued at $23,160,480. This represents a 15.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Jacob Dewitte sold 840,000 shares of the firm’s stock in a transaction dated Monday, December 22nd. The shares were sold at an average price of $82.32, for a total transaction of $69,148,800.00. Following the completion of the transaction, the chief executive officer directly owned 1,580,000 shares in the company, valued at approximately $130,065,600. This represents a 34.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 2,067,583 shares of company stock valued at $170,285,400. 18.90% of the stock is owned by insiders.

Institutional Trading of Oklo

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Gilpin Wealth Management LLC acquired a new stake in shares of Oklo during the 4th quarter worth approximately $29,000. Kemnay Advisory Services Inc. acquired a new position in Oklo during the fourth quarter valued at approximately $35,000. Litman Gregory Wealth Management LLC bought a new stake in Oklo during the fourth quarter worth $36,000. EverSource Wealth Advisors LLC lifted its stake in Oklo by 1,236.7% during the second quarter. EverSource Wealth Advisors LLC now owns 655 shares of the company’s stock worth $37,000 after purchasing an additional 606 shares during the last quarter. Finally, CrossGen Wealth LLC acquired a new stake in shares of Oklo in the 4th quarter valued at $45,000. Institutional investors own 85.03% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on OKLO. UBS Group reiterated a “neutral” rating on shares of Oklo in a research report on Monday, January 12th. Weiss Ratings reissued a “sell (d)” rating on shares of Oklo in a research report on Thursday, January 22nd. Wedbush reaffirmed an “outperform” rating on shares of Oklo in a research report on Friday, January 9th. Barclays dropped their price objective on shares of Oklo from $146.00 to $82.00 and set an “overweight” rating for the company in a research note on Monday, February 23rd. Finally, Texas Capital raised shares of Oklo to a “strong-buy” rating in a report on Tuesday, January 27th. Two analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Oklo has a consensus rating of “Moderate Buy” and an average target price of $91.47.

Trending Headlines about Oklo

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: DOE approved a Nuclear Safety Design Agreement (NSDA) for Atomic Alchemy’s Groves Isotopes Test Reactor — a meaningful step toward project funding/construction and potential isotope revenue. Read More.
• Positive Sentiment: Atomic Alchemy, an Oklo subsidiary, received an NRC materials/isotope license — opens immediate pathway to isotope handling and early revenue streams while core reactor commercialization continues. Read More.
• Positive Sentiment: Some sell-side support remains: HC Wainwright reaffirmed a Buy and set a $90 price target, signaling continued analyst conviction in Oklo’s longer-term potential. Read More.
• Neutral Sentiment: Analysts adjusted price targets — Canaccord cut its target from $175 to $125 and Needham cut from $135 to $73, but both kept Buy ratings; these moves lower upside projections while maintaining institutional support. Read More.
• Neutral Sentiment: Media coverage highlights the Meta power-campus tie-up and a potential uranium/HALEU JV with Centrus, which fuels upside narratives but also draws scrutiny on execution and cash burn. Read More.
• Negative Sentiment: Oklo missed Q4 EPS estimates (reported ($0.27) vs. consensus ($0.17)), reinforcing that the company remains pre-revenue and loss-making near term. Read More.
• Negative Sentiment: Large insider sales reported: CEO Jacob Dewitte and CFO Richard Bealmear sold significant blocks around $60 — such notable dispositions from senior management can increase selling pressure and raise investor concerns. Read More. Read More.

Oklo Company Profile

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.